Key facts
- Daniel Louis Kaufman filed SCHEDULE 13G for ABEONA THERAPEUTICS INC. Common Stock, $0.01 par value (ABEO).
- Disclosed ownership: 5.2%.
- Date of event: 26 Mar 2026.
Daniel Louis Kaufman - 26 Mar 2026 SCHEDULE 13G Report for ABEONA THERAPEUTICS INC. Common Stock, $0.01 par value (ABEO)
- Filing Manager
- Daniel Louis Kaufman
- Reporting Manager
- Daniel Kaufman
- Symbol
- ABEO
- Shares outstanding
- 57,047,074 shares
- Disclosed Ownership
- 2,943,629 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 27 Mar 2026, 14:48:53 UTC
- Date of event
- 26 Mar 2026
- SEC
- View on sec.gov
Key filing fact
Daniel Louis Kaufman disclosed 5.2% ownership in ABEONA THERAPEUTICS INC. Common Stock, $0.01 par value (ABEO) on 26 Mar 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 Mar 2026, 14:48.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Daniel Kaufman | 5.2% | 2,943,629 | 2,943,629 | 0 | /s/ Daniel Kaufman | Daniel Kaufman, Individual Investor |
CIK / CUSIP context first